Announced Fri, 10 Jul · 18:15 IST
Akums Drugs 22nd AGM held via video conferencing; dividend, MD pay revisions tabled
Board & Shareholder Meetings View source PDF
AKUMS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-2.3%1-day move
₹703.20
prior close
₹694.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+1.0+1.3+2.8+1.1-2.3-1.5-2.9-5.4-3.8-1.0————
Up moveDown movePending
AI summary
Akums Drugs held its 22nd AGM on July 10, 2026 via video conferencing. Chairman called FY 2025-26 a year of progress. Six resolutions tabled covering FY26 financials, dividend, re-appointment of Mr Sanjay Sinha, cost auditor pay ratification, and pay revision for MDs Mr Sanjeev Jain and Mr Sandeep Jain. Updates include a Zambia joint venture for a Lusaka pharma plant and a European CDMO contract. 123 members attended. E-voting results to follow.
Likely market impact
AGM summary filed: dividend and MD pay revision tabled. Voting outcome pending. Zambia JV and European CDMO deal point to global expansion.